AZTR Azitra Inc
$1.12▼ -26.80%
Healthcare
Other
After hours
$1.18▲ +5.36%
Oct 27, 6:00 PM ET
Volume 7.06M
Avg Volume (10D) 14.76M
Key Metrics & Fundamentals
Market Cap
$6.79M
P/E Ratio
6.6
Div Yield
0.00%
52W Range
0.52 - 7.63
% vs 50 MA
421.90%
% vs 200 MA
447.41%
RSI-14
73.7
MACD Histogram
+0.1300
Beta (1Y vs SPY)
-6.67
Free Cash Flow
-$3.41M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.23M
COGS
–
Operating Exp
$3.42M
Operating Income
-$3.42M
EBIT
-$3.42M
Pretax Income
-$3.35M
Net Income
-$3.35M
EPS (Diluted)
-0.17
Price & Volume History
Loading chart…
Recent News
Top Premarket Decliners
MT Newswires · Oct 27, 2026 7:40 AM ET
Azitra, Inc. Announces Revitalizing Results from Ex Vivo Study of ATR-COSF Demonstrating Ability to Reduce Fine Lines and Improve Elasticity in Human Skin
PR Newswire · Oct 26, 2026 8:45 AM ET
Azitra, Inc. Announces Reverse Stock Split
PR Newswire · Oct 16, 2026 8:00 AM ET
Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
PR Newswire · Oct 1, 2026 8:00 AM ET
AZTR: Updated Valuation Reflects Cosmetic and EGFRi Rash Programs
Zacks Small Cap Research · Sep 28, 2026 5:32 AM ET
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire · Sep 8, 2026 8:00 AM ET
Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards
PR Newswire · Aug 21, 2026 8:00 AM ET
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
PR Newswire · Aug 12, 2026 5:00 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AZTR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.